Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 17 studies | 26% ± 9% | |
| ciliated cell | 12 studies | 26% ± 10% | |
| oligodendrocyte | 10 studies | 26% ± 9% | |
| microglial cell | 9 studies | 28% ± 10% | |
| oligodendrocyte precursor cell | 9 studies | 25% ± 11% | |
| B cell | 8 studies | 22% ± 5% | |
| macrophage | 8 studies | 32% ± 10% | |
| epithelial cell | 7 studies | 34% ± 15% | |
| adipocyte | 7 studies | 21% ± 6% | |
| GABAergic neuron | 7 studies | 39% ± 19% | |
| endothelial cell of lymphatic vessel | 6 studies | 26% ± 6% | |
| glutamatergic neuron | 6 studies | 44% ± 23% | |
| interneuron | 6 studies | 39% ± 20% | |
| type I pneumocyte | 6 studies | 23% ± 7% | |
| astrocyte | 6 studies | 30% ± 9% | |
| fibroblast | 6 studies | 19% ± 5% | |
| neuron | 5 studies | 40% ± 14% | |
| dendritic cell | 5 studies | 23% ± 6% | |
| type II pneumocyte | 5 studies | 22% ± 5% | |
| goblet cell | 5 studies | 29% ± 16% | |
| club cell | 5 studies | 24% ± 8% | |
| retinal bipolar neuron | 4 studies | 18% ± 1% | |
| lymphocyte | 4 studies | 25% ± 7% | |
| myeloid cell | 4 studies | 22% ± 1% | |
| natural killer cell | 3 studies | 20% ± 2% | |
| naive B cell | 3 studies | 18% ± 1% | |
| retinal ganglion cell | 3 studies | 27% ± 5% | |
| plasma cell | 3 studies | 24% ± 6% | |
| CD4-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| cardiac muscle cell | 3 studies | 16% ± 1% | |
| mononuclear phagocyte | 3 studies | 17% ± 1% | |
| ON-bipolar cell | 3 studies | 19% ± 2% | |
| glycinergic amacrine cell | 3 studies | 19% ± 4% | |
| retinal rod cell | 3 studies | 18% ± 1% | |
| rod bipolar cell | 3 studies | 22% ± 2% | |
| hepatocyte | 3 studies | 37% ± 13% | |
| amacrine cell | 3 studies | 17% ± 1% | |
| T cell | 3 studies | 24% ± 2% | |
| monocyte | 3 studies | 23% ± 1% | |
| basal cell | 3 studies | 30% ± 12% | |
| transit amplifying cell | 3 studies | 28% ± 17% | |
| smooth muscle cell | 3 studies | 19% ± 1% | |
| mast cell | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2628.30 | 1445 / 1445 | 100% | 22.20 | 183 / 183 |
| breast | 100% | 3387.14 | 459 / 459 | 100% | 34.37 | 1117 / 1118 |
| prostate | 100% | 4037.10 | 245 / 245 | 100% | 28.66 | 501 / 502 |
| ovary | 100% | 3299.86 | 180 / 180 | 100% | 20.77 | 429 / 430 |
| thymus | 100% | 3423.13 | 653 / 653 | 100% | 23.54 | 603 / 605 |
| uterus | 100% | 3560.90 | 170 / 170 | 100% | 17.13 | 457 / 459 |
| pancreas | 100% | 2735.22 | 328 / 328 | 99% | 18.11 | 177 / 178 |
| lung | 100% | 2760.00 | 577 / 578 | 99% | 17.67 | 1149 / 1155 |
| bladder | 100% | 3241.05 | 21 / 21 | 99% | 18.57 | 499 / 504 |
| stomach | 100% | 2687.55 | 359 / 359 | 99% | 19.64 | 283 / 286 |
| liver | 100% | 2013.23 | 226 / 226 | 98% | 12.40 | 398 / 406 |
| intestine | 100% | 3405.47 | 966 / 966 | 98% | 17.49 | 516 / 527 |
| kidney | 100% | 2882.61 | 89 / 89 | 97% | 20.31 | 876 / 901 |
| brain | 99% | 2316.27 | 2620 / 2642 | 98% | 14.61 | 691 / 705 |
| adrenal gland | 100% | 2820.81 | 258 / 258 | 97% | 20.04 | 223 / 230 |
| skin | 100% | 2482.99 | 1808 / 1809 | 82% | 9.56 | 385 / 472 |
| adipose | 100% | 2589.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2667.53 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 12.67 | 29 / 29 |
| spleen | 100% | 3685.07 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 14.60 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.05 | 1 / 1 |
| muscle | 100% | 2330.56 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 1532.06 | 828 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 87% | 2317.14 | 804 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 59% | 7.69 | 47 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF33A |
| Protein name | Zinc finger protein 33A ZNF33A protein Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31) Zinc finger protein 33A (cDNA: FLJ23404 fis, clone HEP18862) |
| Synonyms | ZNF11A KOX31 hCG_2017529 ZNF33 ZNF11 KIAA0065 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000628825.2 [Q06730-3] Q8N6F5 A0A0A0MRS1 ENST00000469037.2 A0AUX1 Q05D89 ENST00000307441.13 ENST00000432900.7 [Q06730-2] ENST00000458705.6 [Q06730-1] Q9H5I4 ENST00000374618.7 Q06730 A0A0A0MR11 |